Peptide blocks DNA breaks tied to treatment-induced leukemia, offering new prevention route
A peptide has been identified that prevents DNA breaks linked to secondary leukemias caused by cancer treatments. These breaks often result from cellular stress due to chemotherapy or radiotherapy and can lead to genetic rearrangements that cause leukemia. The discovery offers a potential new approach for preventing this serious long-term complication.
A peptide has been found to block DNA breaks linked to secondary leukemias caused by cancer treatments.
This discovery could lead to new ways to prevent a serious long-term side effect of cancer therapies.
It highlights progress in reducing the harm of treatments, improving quality of life for cancer survivors.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.